4.5 Review

Targeted therapies for immune thrombocytopenic purpura: a meta-analysis of randomized controlled trials

Related references

Note: Only part of the references are listed.
Article Hematology

Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment

Nichola Cooper et al.

Summary: ITP patients and physicians largely align in terms of diagnosis, symptoms, and treatment use, with certain differences noted in specific areas such as fatigue. Understanding the emotional and clinical toll of ITP on the patient will facilitate shared decision-making and appropriate treatment selection based on disease stage.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Hematology

Management of major bleeds in patients with immune thrombocytopenia

Siraj Mithoowani et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

American Society of Hematology 2019 guidelines for immune thrombocytopenia

Cindy Neunert et al.

BLOOD ADVANCES (2019)

Article Oncology

Immune Thrombocytopenia

Gaurav Kistangari et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)

Article Medicine, General & Internal

Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura

James B. Bussel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Mathematical & Computational Biology

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

MJ Sweeting et al.

STATISTICS IN MEDICINE (2004)